Back
CRISPR Therapeutics AG Stock Predictions
1.5 Million Users. Zero Hype. Still Private.
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
45
CRSP
CRISPR Therapeutics AG
Last Price:
$48.80
Seasonality Move:
-2.03%
7 Day Trial
ALL ACCESS PASS
$
7
$10K Investment in Nvidia Could've Made $2.5M
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCRISPR Therapeutics AG Stock Forecast
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 34.7% based on the past 9 years of stock performance.
-
CRISPR Therapeutics AG has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is CRISPR Therapeutics AG Stock Undervalued?The current CRISPR Therapeutics AG [CRSP] share price is $48.74. The Score for CRSP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 34.7% based on the past 9 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
45
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
-
CRISPR Therapeutics AG has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
78.48
52-Week Low:
30.04
Prediction Charts
Market Cap:
4.6B
Price in USD:
48.74
Volume:
1.7M
Beta:
2.05
Technical Analysis
SMA50:
54.64
SMA100:
58.66
SMA200:
53.53
52-Wk Change:
20.02%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?Yes, CRISPR Therapeutics AG is a publicly traded company.
-
What is the CRISPR Therapeutics AG stock quote today?The CRISPR Therapeutics AG stock price is 48.74 USD today.
-
How to buy CRISPR Therapeutics AG stock online?You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 52.02 | 52.61 | 53.46 | 51.00 |
| Jan-21 | 52.14 | 54.73 | 54.81 | 51.80 |
| Jan-22 | 54.53 | 60.81 | 60.86 | 54.22 |
| Jan-23 | 60.70 | 55.52 | 60.70 | 55.05 |
| Jan-26 | 54.77 | 54.65 | 55.71 | 53.72 |
| Jan-27 | 55.50 | 54.26 | 56.69 | 53.57 |
| Jan-28 | 54.30 | 53.69 | 54.63 | 53.07 |
| Jan-29 | 53.03 | 53.35 | 54.09 | 52.67 |
| Jan-30 | 52.12 | 49.96 | 53.84 | 49.73 |
| Feb-2 | 49.50 | 51.31 | 51.92 | 49.10 |
| Feb-3 | 51.23 | 52.00 | 53.00 | 50.61 |
| Feb-4 | 51.89 | 50.17 | 52.37 | 48.82 |
| Feb-5 | 48.86 | 45.88 | 49.63 | 45.53 |
| Feb-6 | 47.22 | 48.74 | 48.99 | 46.27 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $0.36 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.